The prognosis for hormonal cancers varies depending on the type and stage of cancer, as well as the presence of hormone receptors. Generally, cancers that are hormone receptor-positive tend to respond well to hormone therapy and have a better prognosis. Early detection and personalized treatment plans are key factors in improving outcomes.
